Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial
about
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial
description
article publié dans la revue scientifique Journal of the American Medical Association
@fr
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Journal of the American Medical Association
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Effect of Piperacillin-Tazobac ...... e: A Randomized Clinical Trial
@en
Effect of Piperacillin-Tazobac ...... e: A Randomized Clinical Trial
@nl
type
label
Effect of Piperacillin-Tazobac ...... e: A Randomized Clinical Trial
@en
Effect of Piperacillin-Tazobac ...... e: A Randomized Clinical Trial
@nl
prefLabel
Effect of Piperacillin-Tazobac ...... e: A Randomized Clinical Trial
@en
Effect of Piperacillin-Tazobac ...... e: A Randomized Clinical Trial
@nl
P2093
P50
P356
P1476
Effect of Piperacillin-Tazobac ...... e: A Randomized Clinical Trial
@en
P2093
Ahmed Zikri
Anton Y Peleg
David Looke
Eugene Athan
Genevieve Walls
Hasan Bhally
Jon Iredell
MERINO Trial Investigators and ...... al Research Network (ASID-CRN)
Marco Falcone
P304
P356
10.1001/JAMA.2018.12163
P407
P50
P577
2018-09-01T00:00:00Z